Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Barclays analysts attending the SMU Steel Summit 2026 in Atlanta reported persistent domestic supply shortages as the main issue facing steel buyers. Despite more than 50% price increases over the past year, demand remains broadly solid across industrial markets, with construction showing a mixed picture. Rising US-Canada trade tensions add uncerta…
Cogent Biosciences (COGT) has lined up three regulatory filings for bezuclastinib across Non-Advanced Systemic Mastocytosis (NonAdvSM), Advanced Systemic Mastocytosis (AdvSM) and GIST. FDA acceptance and robust SUMMIT data support a tactical long into the late-2026 decision window. Entry at $37.00, stop at $30.00, target $60.00, long term (180 trad…
Joby has industry-leading progress on FAA certification and deep pockets from partners, yet the stock remains priced for perfection (price-to-sales ~61x) and management's recent capital actions have increased dilution risk. Trade the squeeze between regulatory headlines and financing overhang: short with a tight stop and a mid-term horizon to captu…
Celsius Holdings shares fell 5.2% in pre-open trading after Deutsche Bank moved its rating from Buy to Hold while raising the price target to $35 from $30. The change reflects a view that risk-reward near current levels is less attractive, coming after Q2 2026 results that showed a decline in core brand revenue, a miss on adjusted EPS and sharply c…
Biomerica, Inc., a Nasdaq-listed biomedical diagnostics company, announced a $2.23 million private placement priced at $1.60 per share with participation from B. Riley Principal Capital, company executives, and board members. The proceeds will bolster the company's financial position, support ongoing operations, and facilitate evaluation of strateg…
TransUnion's new analysis finds consumers enrolling in third-party debt settlement programs experience greater credit score declines than bankruptcy filers. Nearly half of enrollees were current on payments prior to enrollment. Combining bankruptcy-related signals with credit trend data improves identification of consumers likely to enter debt sett…
Our Bond, Inc., an AI-powered preventative personal security platform company, has signed a definitive agreement with the City of Jerusalem to provide security services to approximately 10,000 municipal employees. This follows a successful pilot and solidifies Bond's government-to-consumer growth strategy. The deal highlights the scalability and ef…
Callan JMB Inc., through its subsidiary Callan Power LLC, announced the acquisition of non-operated working interest in 377 producing oil and gas wells and additional 27 wells in process across the Williston Basin for $12.5 million in cash. The assets have an independently estimated proved PV-10 value of approximately $48 million and total 3P PV-10…
ZenaTech, Inc. announced that its subsidiary ZenaDrone has won the 'Drone Technology of the Year' award by the AgTech Breakthrough Awards for its AI-powered drones advancing precision agriculture. Their drone solutions, currently in testing and pilot stages, assist farmers in early crop stress detection, precise irrigation, fertilizer application, …
Quanta Services (PWR) has been hit by a rapid derating from its 2026 highs. The selloff creates a favorable risk-reward: the company sports a near-record backlog, healthy free cash flow and shareholder-friendly actions, while valuation and sentiment have pulled back enough to justify a tactical long. This trade idea lays out an entry at $620.00, a …
Synopsys is the core EDA and IP provider quietly baked into the chip design flows that power next-generation AI chips. With a $78.5B market cap, $2.75B in free cash flow and partnership momentum around agentic engineering toolkits, the stock looks like a tactical buy on strength in design automation demand. This trade plan buys the stock near curre…
GSK ($51.44) combines a resilient commercial franchise, meaningful vaccine exposure and a mid-teens P/E with a 3.4% yield. Technicals are neutral-to-bullish and the company sits squarely in expanding vaccine markets (influenza, HPV). I recommend a long trade sized for a diversified portfolio: entry $51.40, primary target $62.00, stop loss $48.00, h…
Harmony Biosciences Holdings, Inc., a pharmaceutical company focused on rare neurological diseases, announced that its management team will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on September 10, 2026, with a webcast available to investors.
BranchOut Food Inc. has priced an underwritten public offering of 820,588 shares at $3.40 per share, aiming to raise approximately $2.79 million in gross proceeds. The funds will be used for working capital and general corporate purposes. The offering is expected to close on or about August 28, 2026.
AZIO AI Holdings, Inc. has expanded its agreement with Power Champion Investment Limited to potentially provide up to 512 NVIDIA HGX B300 GPU systems, increasing the estimated sales pipeline value to approximately $307 million. This expansion follows the company's announcement of Atlas One, a South Texas AI compute infrastructure campus engineered …
BranchOut Food Inc. announced initial commercial orders totaling approximately $750,000 for its new front-of-club Crunchy Fruit Chip Multipack Product Line and shelf-stable Dried Cheesecake Bites with the nation’s largest warehouse club retailer. The multipack line is set for launch in Mexico, marking the company's first international warehouse clu…
SL Science Holding Limited filed a new Drug Master File with the FDA covering exosomes derived from Gamma Delta T cells. This expands their regulatory documentation beyond just the GDT cells to include the cell-free exosomes, potentially accelerating future development programs. The exosome format may overcome delivery challenges in oncology, notab…
PodcastOne has acquired exclusive sales and distribution rights to the entertainment podcast ‘Dropping Names… and Other Things with Brent & Jonny,’ hosted by actors Brent Spiner and Jonathan Frakes. This deal expands PodcastOne's portfolio with its 12th new podcast addition this year, broadening its reach in the entertainment podcast sector and enh…
Red Violet, Inc., a leading identity intelligence and analytics company, announced its participation at Citi's 2026 Global TMT Conference. The company’s CEO and CFO will present and host investor meetings, highlighting its proprietary identity intelligence technologies and AI-powered platform CORE™ used for identity verification, risk mitigation, a…
Artelo Biosciences, a clinical-stage pharmaceutical company, declared a 1-for-9 reverse stock split of its common stock effective August 31, 2026. This corporate action aims to increase the stock price per share to enhance liquidity and marketability without changing shareholder ownership percentages. All outstanding warrants and derivatives will b…
CytomX Therapeutics announced that the FDA has granted Fast Track Designation to its investigational drug Varsetatug masetecan (Varseta-M) for treating relapsed/refractory metastatic colorectal cancer (R/R mCRC). This designation follows encouraging Phase 1 data and is intended to expedite development and review. CytomX plans to initiate a registra…
Enviri Corporation (NYSE: NVRI), a leading environmental and operational solutions provider in the metal and rail industries, announced its management will participate in the Jefferies Global Industrials Conference and the Lake Street Best Ideas Growth Conference in New York on September 9 and 10, 2026 respectively. The participation underscores En…
HealthEquity, Inc. announced robust financial results for the second quarter ended July 31, 2026, including a 10% increase in net income to $65.6 million, an 11% increase in adjusted EBITDA to $167 million, and an 8% rise in revenue to $350.7 million. The company reported record levels in HSA accounts and assets, reflecting strong growth and operat…
Milestone Pharmaceuticals announced data from a longitudinal study showing that paroxysmal supraventricular tachycardia (PSVT) significantly affects patients' daily lives and quality of life even between acute episodes. The study highlights lifestyle changes, activity avoidance, persistent anxiety, and medication side effects as contributors to the…
Freshpet, a company specializing in refrigerated, fresh pet foods, announced its participation in the Barclays 19th Annual Global Consumer Conference. The event will include a management presentation and webcast outlining their business approach and growth strategy.
